MedTech Medical Device R&D | Scalanova Health

Engineering in a Clinical Vacuum is a Market Risk

The greatest friction in MedTech scaling isn’t the code — it’s the context. When generalist engineers build medical devices without real-world clinical oversight, the result is a product that fails the Practitioner’s Logic test. This creates a Translation Gap that leads to ergonomic failure, regulatory pushback, and a stalled time-to-market.

Scalanova Health eliminates this vacuum. We build engineering pods where practicing surgeons, dentists, and diagnostic veterans govern the technical roadmap, ensuring your technology is built for the patient bedside and the operating theater, not just the lab.

Agentic Solutions for Clinical Precision

Autonomous engineering pods governed by active clinicians to master the full lifecycle of medical technology.

Surgical & Robotic
Systems

Architecture and engineering of high-precision motion control and autonomous logic. Proven expertise in robotic exoskeletons and advanced surgical planning tools.

Diagnostic & Screening
Platforms

Development of AI-driven cancer screening systems and decentralized “Lab in a Bag” platforms capable of 150+ portable pathology tests.

Specialized Clinical
Devices

End-to-end R&D for high-stakes dental and maxillofacial surgical hardware, oral health diagnostics, and patient-specific implant logic.

Full-Lifecycle Capabilities

Beyond R&D, we provide end-to-end support for clinical trials and comprehensive regulatory certifications across all medical device categories.

Practitioner-Led Governance: Validated in the Clinical Sandbox

At Scalanova Health, your technical roadmap is overseen by our Council of active practitioners who navigate the complexities of live clinical environments every day.

Phase I: Clinical Logic Alignment

We map your device requirements to real-world workflows—from neurosurgery to dentistry—before prototyping begins.

Phase II: Sandbox Stress-Testing

Leverage our successful track record, including robotic exoskeletons that passed clinical trials at Nirmal Neurocare, and our broader network of affiliated multi-specialty hospitals.

Phase III: End-to-End Regulatory Services

Full-lifecycle management for US FDA, CE, and CDSCO (India) submissions, providing the clinical evidence required for global market entry.

De-Risk Your Engineering Lifecycle

For MedTech scale-ups and diagnostic leaders, a Scalanova Health Innovation Pod is a de-risking engine. By providing end-to-end clinical trials and regulatory certifications, we eliminate the hurdles between prototype and market.

Whether you are deploying cancer screening devices in emerging markets or developing the next generation of portable pathology, we provide the Clinical Sandbox and the regulatory expertise required to move from prototype to market-ready asset with institutional velocity.

Clinical Sandbox Validation FAQs

We align all MedTech R&D with international regulatory baselines from day one. Our clinical advisory council and legal partners, Stride Legal, build GxP-compliant and ISO 13485 aligned processes directly into your dedicated GCC workflows. This architecture ensures that all structural, software, and mechanical outputs are fully pre-validated for US FDA, CE Mark, and Indian FDA (CDSCO) submission pipelines, radically shortening your time-to-market and removing downstream regulatory friction.

Ensure your device development meets high-stakes compliance standards from day one.

Yes. We design our MedTech engineering pods with an API-first framework specifically engineered to bridge the gap between legacy surgical setups and modern, AI-driven motion planning. Whether you are interfacing with proprietary robotic kinematics, custom imaging systems, or legacy hardware middleware, our teams architect secure, high-fidelity orchestration layers that ensure seamless data synchronization and zero latency—all without requiring a high-risk, expensive overhaul of your existing physical asset.

Discuss your custom hardware integration requirements with our technical lead under NDA.

Traditional vendors rely on structural lock-in. Scalanova Health’s BOT framework acts as a local incubator, establishing a private, highly secure Indian GCC dedicated exclusively to your corporate brand. All custom surgical algorithms, kinematics models, and mechanical blueprints remain $100%$ your proprietary property throughout the lifecycle before clean, seamless legal transfer.

Secure your proprietary AI-native infrastructure.

Securing clinical validation loops and hospital access for testing medical software or prototypes in Western markets can take 12 to 18 months and cost millions. Scalanova Health bridges this gap by offering our clients exclusive access to our network of affiliated multispecialty clinical partners. This secure environment allows our engineering pods to rapidly stress-test AI models, surgical trajectory paths, and clinical UI/UX in live, operational settings. This close feedback loop helps you identify edge-case issues early, iterate on clinical logic at a fraction of Western costs, and arrive at pivotal clinical trials with a highly resilient, pre-validated asset.

To learn more about our affiliated clinical environments and validation case studies under active NDAs.

Validate Your Logic in a Live Clinical Environment

Deploy your autonomous Agentic AI workforce to bridge the Translation Gap and accelerate your top line